Article
Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery
Article first published online: 9 OCT 2012
DOI: 10.1002/pro.2155
Copyright © 2012 The Protein Society
Additional Information
How to Cite
Lindert, S. and McCammon, J. A. (2012), Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery. Protein Science, 21: 1734–1745. doi: 10.1002/pro.2155
Publication History
- Issue published online: 16 OCT 2012
- Article first published online: 9 OCT 2012
- Accepted manuscript online: 11 SEP 2012 01:07PM EST
- Manuscript Accepted: 30 AUG 2012
- Manuscript Revised: 20 AUG 2012
- Manuscript Received: 1 JUL 2012
Funded by
- National Science Foundation. Grant Number: PHY-0822283, MCB 1020765
- National Institutes of Health
- Howard Hughes Medical Institute
- National Biomedical Computation Resource
- NSF Supercomputer Centers
- American Heart Association
- Center for Theoretical Biological Physics
Keywords:
- molecular dynamics;
- protein–drug interactions;
- computer-aided drug discovery;
- enoyl-acyl carrier protein reductase
Abstract
Enoyl-acyl carrier protein reductase (ENR) is a crucial enzyme in the type II fatty acid synthesis pathway of many pathogens such as Plasmodium falciparum, the etiological agent of the most severe form of malaria. Because of its essential function of fatty acid double bond reduction and the absence of a human homologue, PfENR is an interesting drug target. Although extensive knowledge of the protein structure has been gathered over the last decade, comparatively little remains known about the dynamics of this crucial enzyme. Here, we perform extensive molecular dynamics simulations of tetrameric PfENR in different states of cofactor and ligand binding, and with a variety of different ligands bound. A pocket-volume analysis is also performed, and virtual screening is used to identify potential druggable hotspots. The implications of the results for future drug-discovery projects are discussed.

1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
